Pro Medicus (OTCMKTS:PMCUF – Get Free Report) is expected to announce its results before the market opens on Tuesday, August 18th. Analysts expect the company to post earnings of $0.4860 per share and revenue of $94.3880 million for the quarter.
Pro Medicus Price Performance
Shares of OTCMKTS PMCUF opened at $122.00 on Tuesday. Pro Medicus has a 1 year low of $74.52 and a 1 year high of $210.25. The firm has a 50-day simple moving average of $123.44 and a two-hundred day simple moving average of $105.53.
Wall Street Analysts Forecast Growth
Separately, Jefferies Financial Group cut Pro Medicus from a “buy” rating to a “hold” rating in a research note on Wednesday, July 8th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company presently has a consensus rating of “Hold” and a consensus target price of $155.00.
About Pro Medicus
Pro Medicus Limited is an Australia‐based healthcare technology company specializing in advanced medical imaging IT solutions. Its core offerings include radiology information systems (RIS), picture archiving and communication systems (PACS), and enterprise imaging platforms designed to streamline diagnostic workflows and enhance image management for healthcare providers.
The company’s flagship product suite, Visage 7, delivers high-performance visualization and reporting capabilities, enabling radiologists to access and manipulate large datasets with minimal latency.
Featured Stories
- Five stocks we like better than Pro Medicus
- SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
- 3 Dividend Champion Utilities for a Market That Can’t Sit Still
- These 3 Most-Upgraded Stocks Have Almost Nothing to Do With AI
- First Solar’s Profit Engine Faces a New Policy Test in Washington
Receive News & Ratings for Pro Medicus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro Medicus and related companies with MarketBeat.com's FREE daily email newsletter.
